SCHEMBL6011973

SCHEMBL6011973

Nc1ncc2nc(C(=O)OCc3ccccc3)cnc2n1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ MAPT P10636 4/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ SLC6A2 P23975 1/20 0.43
▸ SLC6A3 Q01959 1/20 0.43
▸ POLB P06746 2/20 0.43
▸ DHFR P00374 1/20 0.42
▸ LMNA P02545 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 3/20 0.41
▸ GAA P10253 2/20 0.41
▸ MAOB P27338 1/20 0.41
▸ ADORA2A P29274 1/20 0.41
▸ GLA P06280 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6616258 0.80 KMT2A (0.60) KMT2AMEN1MAPTTDP1SLC6A2
SCHEMBL24269953 0.78 MAPT (0.54) KMT2AMAPTTDP1SLC6A2SLC6A3
SCHEMBL24414105 0.76 TDP1 (0.50) KMT2AMAPTTDP1SLC6A2SLC6A3
SCHEMBL25682098 0.75 RAB9A (0.54) KMT2AMAPTTDP1SLC6A2SLC6A3
SCHEMBL6012026 0.75 TSHR (0.43) MAPTDHFRLMNANPSR1
SCHEMBL3352990 0.74 POLB (0.57) KMT2AMAPTTDP1SLC6A2SLC6A3
SCHEMBL21095221 0.74 TDP1 (0.64) KMT2AMAPTTDP1SLC6A2SLC6A3
SCHEMBL24414096 0.73 TDP1 (0.51) KMT2AMEN1MAPTTDP1SLC6A2
SCHEMBL6011978 0.73 ALDH1A1 (0.49) KMT2AMEN1MAPTPOLBDHFR
SCHEMBL24674211 0.72 EGLN1 (0.44) KMT2AMAPTTDP1SLC6A2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1701957-A1 2-AMINO-O4-SUBSTITUTED PTERIDINES AND THEIR USE AS INACTIVATORS OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) 2006-09-20 — — EP disclosed
WO-2005068465-A1 2-AMINO-O4-SUBSTITUTED PTERIDINES AND THEIR USE AS INACTIVATORS OF O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2005-07-28 — — WO disclosed
Send feedback